The researchers analyzed the drugs in overdose patient’s urine collected from January 2016 to December 2019. They found that fentanyl appeared in 73 to 87 percent of the samples during 2019, the first year UMC began testing for it.
The authors of the study suggest that healthcare facilities add fentanyl to their standard drug testing panels, which do not currently include the drug even though it is linked to most opioid overdose cases.
More articles on opioids:
Pharmacy chains helped fuel opioid crisis, complaint alleges
States with legalized medical cannabis prescribe 20% less opioids, study finds
Screen all adults for unhealthy drug use, US task force advises
